FDA Drug information
UPTRAVI
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- UPTRAVI SELEXIPAG 1000 ug/1 Actelion Pharmaceuticals US, Inc.
- UPTRAVI SELEXIPAG 1200 ug/1 Actelion Pharmaceuticals US, Inc.
- UPTRAVI SELEXIPAG 1400 ug/1 Actelion Pharmaceuticals US, Inc.
- UPTRAVI SELEXIPAG 1600 ug/1 Actelion Pharmaceuticals US, Inc.
- UPTRAVI SELEXIPAG 1800 ug/10mL Actelion Pharmaceuticals US, Inc.
- UPTRAVI SELEXIPAG 200 ug/1 Actelion Pharmaceuticals US, Inc.
- UPTRAVI SELEXIPAG 400 ug/1 Actelion Pharmaceuticals US, Inc.
- UPTRAVI SELEXIPAG 600 ug/1 Actelion Pharmaceuticals US, Inc.
- UPTRAVI SELEXIPAG 800 ug/1 Actelion Pharmaceuticals US, Inc.
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.